MedKoo Cat#: 555733 | Name: EB-3D
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

EB-3D is a novel potent and selective choline kinase ChoKα inhibitor. EB-3D Induces Deregulation of the AMPK-mTOR Pathway and Apoptosis in Leukemia T-cells. EB-3D induces senescence in breast cancer cell lines through the activation of the metabolic sensor AMPK and the subsequent dephosphorylation of mTORC1 downstream targets, such as p70S6K, S6 ribosomal protein, and 4E-BP1. Moreover, EB-3D strongly synergizes with drugs commonly used for breast cancer treatment.

Chemical Structure

EB-3D
EB-3D
CAS#1839150-63-8 (bromide)

Theoretical Analysis

MedKoo Cat#: 555733

Name: EB-3D

CAS#: 1839150-63-8 (bromide)

Chemical Formula: C30H36Br2N4O2

Exact Mass: 0.0000

Molecular Weight: 644.45

Elemental Analysis: C, 55.91; H, 5.63; Br, 24.80; N, 8.69; O, 4.97

Price and Availability

Size Price Availability Quantity
50mg USD 550.00 2 Weeks
100mg USD 950.00 2 Weeks
200mg USD 1,450.00 2 Weeks
500mg USD 2,250.00 2 Weeks
1g USD 3,450.00 2 Weeks
2g USD 5,650.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
1839150-62-7 (cation) 1839150-63-8 (bromide)
Synonym
EB-3D; EB 3D; EB3D;
IUPAC/Chemical Name
1,1'-(((ethane-1,2-diylbis(oxy))bis(4,1-phenylene))bis(methylene))bis(4-(dimethylamino)pyridinium) bromide
InChi Key
SCXVGPSPZQBBDM-UHFFFAOYSA-L
InChi Code
InChI=1S/C30H36N4O2.2BrH/c1-31(2)27-13-17-33(18-14-27)23-25-5-9-29(10-6-25)35-21-22-36-30-11-7-26(8-12-30)24-34-19-15-28(16-20-34)32(3)4;;/h5-20H,21-24H2,1-4H3;2*1H/q+2;;/p-2
SMILES Code
CN(C1=CC=[N+](CC2=CC=C(OCCOC3=CC=C(C[N+]4=CC=C(N(C)C)C=C4)C=C3)C=C2)C=C1)C.[Br-].[Br-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Choline kinase alpha 1 (ChoKα1) has recently become an interesting therapeutic target since its overexpression has been associated to tumorigenesis in many cancers.

Preparing Stock Solutions

The following data is based on the product molecular weight 644.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sola-Leyva A, López-Cara LC, Ríos-Marco P, Ríos A, Marco C, Carrasco-Jiménez MP. Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells. Sci Rep. 2019 Mar 25;9(1):5109. doi: 10.1038/s41598-019-40885-z. PMID: 30911014; PMCID: PMC6433853. 2: Mariotto E, Bortolozzi R, Volpin I, Carta D, Serafin V, Accordi B, Basso G, Navarro PL, López-Cara LC, Viola G. EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. Biochem Pharmacol. 2018 Sep;155:213-223. doi: 10.1016/j.bcp.2018.07.004. Epub 2018 Jul 11. PMID: 30006194. 3: Mariotto E, Viola G, Ronca R, Persano L, Aveic S, Bhujwalla ZM, Mori N, Accordi B, Serafin V, López-Cara LC, Bortolozzi R. Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer. Cancers (Basel). 2018 Oct 22;10(10):391. doi: 10.3390/cancers10100391. PMID: 30360374; PMCID: PMC6209942. 4: Qu H, Han Z, Chen Z, Tang L, Gao C, Liu K, Pan H, Fu H, Ruan C. Fractal Design Boosts Extrusion-Based 3D Printing of Bone-Mimicking Radial-Gradient Scaffolds. Research (Wash D C). 2021 Nov 23;2021:9892689. doi: 10.34133/2021/9892689. PMID: 34909694; PMCID: PMC8637129.